Fig. 3From: Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disordersLevels of sAPPα (a), sAPPβ (b), p-tau (c), and Aβ42 (d) across the four groups of patients (AD, MCI-AD, non-AD, and disease control). Significant differences were analyzed by the methods described in Materials and Methods (*p < 0.05, **p < 0.01, ***p < 0.001)Back to article page